Clinical Trial: A Single Dose Phase I Study to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Stem Cells Lenses in the coGVHD Subjects

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06952114) titled 'A Single Dose Phase I Study to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Stem Cells Lenses in the coGVHD Subjects' on April 23.

Brief Summary: This study is a single dose, Phase I study to evaluate the safety, tolerability, and preliminary effectiveness of Stem cells Lenses in the coGVHD Subjects. Three subject's enrollments are Expected. Each subject will wear Stem cells Lenses loaded for four consecutive days. After a 4-day treatment period, a 14-day follow-up observation period will be conducted to monitor for potential adverse events.

This study aims to treat patients with chronic ocular graft-versus-host...